Plunkett Research Online: Allergan plc

ALLERGAN PLC (AGN:NYS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Allergan plc is a global pharmaceutical company focused on developing, manufacturing and commercializing branded pharmaceutical, device, biologic, surgical and regenerative medicine products. The firm’s portfolio features seven franchises in therapeutic categories: dermatology & medical aesthetics,.....



Allergan plc
Ticker: AGN
Exchange: NYS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 441 295 2244
Fax: 714 246-4971
Address: Clonshaugh Business and Technology Park
Coolock
Dublin, D17E400 Ireland

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceutical Development
Eye Care Supplies
Dermatological Products
Neuromodulator Products
Obesity Intervention Products
Urologic Products
Medical Aesthetics
ContactsDescription
Brenton SaundersCEO/Director/President/Chairman of the Board
Matthew WalshCFO
See More

Auditor: PricewaterhouseCoopers LLP
Legal Advisor: Greenberg Traurig, LLP
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Alloderm
Botox
Estrace
Zenpep
Keller Medical Inc
Zeltiq Aesthetics Inc
Coolsculpting
LifeCell Corporation
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors:

U.S. employees of the firm receive medical, long-term care, dental, vision and prescription drug coverage; life, AD&D, business travel accident and disability insurance; group legal services; tuition reimbursement; flexible spending accounts; domestic partner coverage; and pet insurance.